Form 4: Insulet Director Timothy Scannell Receives Annual Equity Award, Boosting Stake

Insulet Corporation's Director, Timothy J. Scannell, was granted 778 restricted stock units as part of an annual equity award, increasing his total beneficial ownership to 31,364 shares.

Summary

• Timothy J. Scannell, a Director of Insulet Corporation (PODD), acquired 778 shares of common stock.
• The acquisition occurred on May 22, 2025, and was an annual equity award in the form of restricted stock units (RSUs).
• These RSUs were acquired at a price of $0 per unit, indicating they were granted as compensation.
• The RSUs will be settled on a one-for-one basis in shares of common stock and are scheduled to vest in full on April 30, 2026.
• Following this transaction, Timothy J. Scannell's beneficial ownership of Insulet common stock increased to 31,364 shares.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally positive as it aligns their interests with shareholders, indicating commitment and confidence in the company's future.

Positives

• The grant of restricted stock units to a director aligns their financial interests with those of the shareholders, encouraging long-term value creation.
• The increase in beneficial ownership by a director demonstrates continued commitment and confidence in the company's future prospects.

Future Outlook

The 778 restricted stock units granted to Director Timothy J. Scannell are scheduled to vest in full on April 30, 2026, at which point they will be settled in shares of Insulet common stock.

Industry Context

This filing reflects a routine annual equity award to a director, a common practice in the medical device and healthcare technology industry to incentivize long-term performance and align management interests with shareholder value.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) as part of director compensation is a standard practice across publicly traded companies, including those in the medical technology sector, to attract and retain qualified board members.
• The structure of these awards, with a future vesting date, is typical for equity compensation, promoting a long-term perspective from board members.

Related Party Transactions

• The acquisition of 778 restricted stock units by Timothy J. Scannell, a Director of Insulet Corporation, constitutes a related party transaction as it involves an insider receiving compensation from the company.

Stakeholder Impact

• Shareholders: The equity award aligns the director's interests with shareholders, potentially leading to better long-term decision-making aimed at increasing shareholder value.

Next Steps

• The 778 restricted stock units are expected to vest on April 30, 2026.

Key Dates

Keywords

Insulet Corporation, PODD, Timothy J. Scannell, SEC Form 4, Restricted Stock Units, RSUs, Equity Award, Insider Trading, Director Compensation, Beneficial Ownership